NVE Corporation (Nasdaq: NVEC) details CEO change and larger board
Rhea-AI Filing Summary
NVE Corporation announced a planned leadership transition and board expansion. Daniel A. Baker will retire as President and Chief Executive Officer effective at the Annual Shareholders’ meeting on August 6, 2026, and, pending shareholder approval, remain on the Board as Chairman.
The Board appointed Peter G. Eames, currently Vice President of Advanced Technology, as the next President and Chief Executive Officer effective at that meeting and nominated him to the Board. The Board also nominated current Chairman Terrence W. Glarner to remain a director and first-time nominee Carolyn W. Valentine to join the Board. If shareholders approve all nominees, the Board will increase from five to seven directors.
The Compensation Committee set Dr. Eames’ annual base salary at $260,000 and approved a performance-based compensation plan equal to 0.3% of fiscal 2027 income from operations plus 2% of the increase in income from operations in fiscal 2027 compared to fiscal 2026. Non-employee directors, if elected or reelected, will receive an immediately vested nonqualified option to purchase 1,000 shares, except Dr. Baker, who will not receive this option if reelected.
Positive
- None.
Negative
- None.
Insights
Orderly CEO succession with internal hire and modest board expansion.
NVE Corporation is executing a planned CEO transition, with long-time leader Daniel Baker retiring from the executive role while remaining Chairman, subject to shareholder approval. The Board chose internal candidate Peter Eames, who has led advanced technology and capital projects since 2016.
This structure emphasizes continuity: the outgoing CEO stays involved at the board level and the new CEO has deep company and technical experience. The board also plans to add Carolyn Valentine, who brings external operating experience in healthcare-related technology, expanding the board from five to seven directors if shareholders approve the slate.
Dr. Eames’ compensation plan ties a portion of pay directly to income from operations in fiscal 2027, aligning incentives with operating performance. Future company filings discussing fiscal 2026 and 2027 results will help illustrate how this new leadership and incentive structure interacts with NVE’s growth and profitability.
8-K Event Classification
Key Figures
Key Terms
income from operations financial
nonqualified option financial
forward-looking statements regulatory
spintronics technical
Nominating/Corporate Governance Committees regulatory
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| ||
( | (Zip Code) |
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered |
The |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 22, 2026, NVE Corporation (the “Company”) announced that Daniel A. Baker, Ph.D., age 68, will retire as President and Chief Executive Officer effective at the Company’s Annual Shareholders’ meeting on August 6, 2026. Pending shareholder approval, Dr. Baker will remain on the Board of Directors as Chairman of the Board. The Board of Directors appointed Peter G. Eames, age 50, currently serving as Vice President of Advanced Technology, as President and Chief Executive Officer effective at that time. He was also nominated to the Company’s Board of Directors.
Dr. Eames has served as Vice President of Advanced Technology since 2016. Prior to that role, he served as Director of Advanced Technology, as a program manager, and as a research scientist. There are no family relationships between Dr. Eames and any director or executive officer of the Company, and there are no arrangements or understandings between Dr. Eames and any other persons pursuant to which he was appointed as an officer of the Company. There are no transactions involving Dr. Eames requiring disclosure under Item 404(a) of Regulation S-K.
Current Chairman Terence W. Glarner, age 83, was nominated to remain on the Board.
Additionally, the Board nominated Caroyln W. Valentine to its Board of Directors. If elected by shareholders, she will join the Compensation and Nominating/Corporate Governance Committees. Ms. Valentine, age 58, is President of Grason-Stadler, a Demant Company. Demant is a publicly traded hearing healthcare and audio technology group, and GSI is a world leader in audiology equipment. There are no arrangements or understandings between Ms. Valentine and any other persons pursuant to which she was nominated. There are no transactions involving Ms. Valentine requiring disclosure under Item 404(a) of Regulation S-K.
In accordance with our standard practice, if elected or reelected, each non-employee director will be automatically granted an immediately vested nonqualified option to purchase 1,000 shares, as described in the Company’s most recent proxy statement. Dr. Baker will not receive such an option if he is reelected.
Directors are indemnified as required under Minnesota Statutes Section 302A.521.
In connection with his appointment as President and Chief Executive Officer, the Compensation Committee approved an annual base salary for Dr. Eames of $260,000 per year, and a performance-based compensation plan of 0.3% of fiscal 2027 income from operations plus 2% of the increase in income from operations in fiscal 2027 compared to fiscal 2026.
Item 8.01. Other Events.
On June 22, 2026 the Company issued a press release announcing the leadership change and board nominations described above. A copy of the press release is furnished as Exhibit 99 to this Current Report on Form 8-K.
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date June 22, 2026 | NVE CORPORATION
|
|
3
INDEX TO EXHIBITS
Exhibit # | Description
|
99 | NVE Corporation press release dated June 22, 2026. |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
4
NVE Corporation Announces CEO Change and Board Expansion
EDEN PRAIRIE, Minn.—June 22, 2026—NVE Corporation (Nasdaq: NVEC) announced today that Daniel A. Baker, Ph.D. will retire as President and Chief Executive Officer effective with the Company’s Annual Shareholders’ meeting on August 6, 2026. The Board of Directors has appointed Peter G. Eames, Ph.D., currently Vice President of Advanced Technology, as President and Chief Executive Officer effective at that time.
Subject to shareholder approval, Dr. Baker will remain on the Company’s Board of Directors as Chairman, current Chairman Terrence W. Glarner will remain on the Board, and Dr. Eames will join the Board. In addition to the incumbent board and Dr. Eames, the Board nominated a new director, Carolyn W. Valentine. Pending shareholder approval, the Board will expand from five to seven directors.
“Leading NVE has been the privilege of a lifetime,” said Dr. Baker. “I am proud of what our team has accomplished and confident the company is well-positioned for continued success under Pete’s leadership.” Baker added, “The Board conducted a thoughtful succession planning process and unanimously selected Pete as the company’s next CEO. Pete brings extraordinary experience, dedication, and judgment, and I know shareholders will be well served by his leadership in the years ahead.”
Baker continued, “I look forward to continuing my commitment to NVE’s success as chairman. The board joins me in thanking Terry Glarner for his more than 25 years of leadership and service as our chairman.”
Baker joined NVE in 2001. During his tenure, the company grew from primarily contract research to a leading provider of advanced spintronics-based products.
Eames has served as Vice President of Advanced Technology since 2016. He has been an NVE employee in various capacities since joining the Company in 2003 after completing his Ph.D. in Experimental Condensed Matter Physics from the University of Minnesota. In his current position he has led the company’s research and development efforts and managed production expansions and major capital investments.
“I am honored to be selected to lead NVE,” said Eames. “We have a talented team, strong customer relationships, and exciting opportunities ahead. I look forward to building on the company’s momentum and continuing to create value for our shareholders, customers, employees, and partners.”
First-time Director nominee Carolyn W. Valentine has served as President of Grason-Stadler, a Demant Company, since October 2023. Demant is a publicly traded hearing healthcare and audio technology group, and GSI is a world leader in audiology equipment.
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.
Statements used in this press release that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as our reliance on several large customers for a significant percentage of revenue, uncertainties related to the economic environments in the industries we serve, uncertainties related to future sales and revenues, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2026.
###